Pathology Doctors in North Kansas City, MO Accepting Medicare

8 Pathology doctors found. Showing 1 - 8

David Eric Ewing, MD Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 2750 Clay Edwards Dr Ste 420, North Kansas City, MO 64116 Phone: 816-241-3338    Fax: 816-936-8118

Edgar L Hunt Jr., MD Pathology - Dermatopathology Medicare: Accepting Medicare Assignments Practice Location: 2750 Clay Edwards Dr, Ste 420, North Kansas City, MO 64116 Phone: 816-241-3338    Fax: 816-936-8118

Pablo J Hernandez-rios, MD Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 2750 Clay Edwards Dr, Suite 420, North Kansas City, MO 64116 Phone: 816-241-0928    Fax: 816-936-8118

Robert L Breckenridge, MD Pathology - Blood Banking & Transfusion Medicine Medicare: Not Enrolled in Medicare Practice Location: 2750 Clay Edwards Dr, Suite 420, North Kansas City, MO 64116 Phone: 816-241-3338    Fax: 816-936-8118

Deborah A Borek, MD Pathology - Blood Banking & Transfusion Medicine Medicare: Not Enrolled in Medicare Practice Location: 2750 Clay Edwards Dr, Suite 420, North Kansas City, MO 64116 Phone: 816-241-3338    Fax: 816-936-8118

Drew D. Nedved, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 2750 Clay Edwards Dr, Suite 420, North Kansas City, MO 64116 Phone: 816-241-0861    Fax: 816-241-6041

Keith A Richards, MD Pathology - Cytopathology Medicare: Not Enrolled in Medicare Practice Location: 2750 Clay Edwards Dr, Suite 420, North Kansas City, MO 64116 Phone: 816-241-3338    Fax: 816-936-8118

Mark T Stivers, MD Pathology - Hematology Medicare: Not Enrolled in Medicare Practice Location: 2750 Clay Edwards Dr, Suite 420, North Kansas City, MO 64116 Phone: 816-241-3338    Fax: 816-936-8118

News Archive

Oraya Therapeutics' IRay stereotactic radiotherapy system granted European CE Mark approval

Oraya Therapeutics, Inc. announces today that a leading European notified body has granted approval to designate the CE mark to Oraya's IRayTM stereotactic radiotherapy system. Under development since 2007, the IRay is designed specifically to treat diseases of the eye, and the technology enables precise delivery of low energy X-rays for the treatment of wet age-related macular degeneration (AMD).

Children from low-income areas have poor outcomes after heart surgery, study finds

Children from low-income neighborhoods had a higher mortality rate and higher hospital costs after heart surgery compared with those from higher-income neighborhoods, found a national study of more than 86,000 kids with congenital heart disease.

Celgene's ISTODAX sNDA granted FDA Priority Review classification for progressive/relapsed PTCL

Celgene Corporation today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review classification to its Supplemental New Drug Application (sNDA) regarding ISTODAX (romidepsin) for injection for the treatment of peripheral T-cell lymphoma (PTCL) in patients who have received at least one prior therapy.

Total joint replacement may reduce risk for cardiac events and boost long-term survival

​Hip and knee replacements have long been known to reduce pain and increase mobility in persons with moderate-to-severe arthritis. A study presented at the 2014 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) also found that total joint replacement (TJR) may reduce the risk for "cardiac events," including heart attack and stroke, and boost long-term survival.

Read more Medical News

› Verified 1 days ago